Autism Spectrum Disorder Diagnostics Market Competition Analysis 2025: How Players Are Shaping Growth

Autism Spectrum Disorder Diagnostics Global Market Report 2025

The Business Research Company's Autism Spectrum Disorder Diagnostics Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034

LONDON, GREATER LONDON, UNITED KINGDOM, December 11, 2025 /EINPresswire.com/ -- "The Autism Spectrum Disorder Diagnostics market is dominated by a mix of global healthcare leaders and specialized diagnostic solution providers. Companies are focusing on AI-enabled diagnostic tools, genetic testing technologies, and behavioral assessment platforms to strengthen their market presence and enhance diagnostic accuracy. Understanding this evolving landscape is crucial for stakeholders seeking strategic collaborations, technology innovation, and long-term growth opportunities in the ASD diagnostics sector.

Which Market Player Is Leading the Autism Spectrum Disorder Diagnostics Market?
According to our research, Laboratory Corporation of America Holdings (LabCorp) led global sales in 2023 with a 2% market share. The LabCorp Diagnostics (Dx) division of the company is completely involved in autism spectrum disorder diagnostics market, offering comprehensive clinical laboratory services, including genetic testing, biochemical analyses and neurodevelopmental assessments for autism spectrum disorder diagnostics. Its offerings include chromosomal microarray analysis, whole exome sequencing and metabolic screening, aiding early detection and personalized care. Labcorp supports clinicians with advanced diagnostics to improve patient outcomes.

How Concentrated Is the Autism Spectrum Disorder Diagnostics Market?
The market is fragmented, with the top 10 players accounting for 6% of total market revenue in 2023. This level of fragmentation reflects the industry’s diverse diagnostic approaches, driven by behavioral, genetic, and AI-assisted testing solutions. Leading vendors such as Laboratory Corporation of America Holdings (LabCorp), Illumina Inc., Bio-Rad Laboratories Inc., and Quest Diagnostics Incorporated dominate through advanced diagnostic technologies, established clinical networks, and strong research capabilities, while smaller firms focus on niche innovations and regional service expansion. As adoption of digital and precision diagnostic tools accelerates, strategic collaborations and technology-driven consolidation are expected to strengthen the position of major players in the coming years.

• Leading companies include:
o Laboratory Corporation of America Holdings (LabCorp) (2%)
o Illumina Inc. (1%)
o Bio-Rad Laboratories Inc. (0.8%)
o Quest Diagnostics Incorporated (0.6%)
o Ambry Genetics Corp. (0.6%)
o ARUP Laboratories Inc. (0.5%)
o Cortica Inc. (0.4%)
o GeneDx Holding Corp. (0.2%)
o Centogene N.V. (0.1%)
o Caravel Autism Health LLC (0.1%)

Request a free sample of the Autism Spectrum Disorder Diagnostics Market Report
https://www.thebusinessresearchcompany.com/sample_request?id=16593&type=smp

Which Companies Are Leading Across Different Regions?
• North America: Linus Biotechnology, Inc., Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., C.A.B.S. Autism and Behavior Specialists, LLC, Schweitzer Engineering Laboratories, Inc., Cognoa, Inc., Quest Diagnostics Incorporated, Marcus Autism Center, EarliTec Diagnostics, Inc., Autism Ontario, Auticon GmbH, Kinark Child and Family Services, and Autism Speaks Inc. are leading companies in this region.
• Asia Pacific: Genetic Technologies Limited (GTG), BGI Genomics Co., Ltd., Berry Genomics Co., Ltd., Annoroad Gene Technology Co., Ltd., KingMed Diagnostics Group Co., Ltd., MedGenome Labs Ltd., AI.gnosis Pte. Ltd., Green Cross Lab Cell Corporation, and Microgen Inc. are leading companies in this region.
• Western Europe: SYNLAB Group, QIAGEN N.V., Paloma Health Ltd., F. Hoffmann-La Roche Ltd., and Merck Sharp & Dohme (MSD) Ireland are leading companies in this region.
• Eastern Europe: EKF Diagnostics Holdings plc, H. Lundbeck A/S, Synevo Medical Laboratory, and Genetica Laboratory are leading companies in this region.
• South America: Diagnostics da América S.A. (DASA), Tismoo.me Inc., SYNLAB Group, F. Hoffmann-La Roche AG, and Quest Diagnostics Incorporated are leading companies in this region.

What Are the Major Competitive Trends in the Market?
Diagnostic Aid for Autism Spectrum Disorder (ASD) is advanced test analyses enhance early detection
• Example: LinusBio ClearStrand-ASD (February 2025) assigns advanced test analyzes a single strand of hair to help clinicians rule out ASD in children aged 1 to 36 months by examining biomarkers that reflect metabolic history.
• These innovation helps to streamline the diagnostic process, ClearStrand-ASD enhances clinical decision-making and improves patient outcomes.

Which Strategies Are Companies Adopting to Stay Ahead?
• Launching innovative diagnostic tools and biomarker-based testing solutions
• Enhancing strategic funding and research collaborations
• Focusing on digital health platforms and tele-diagnostic solutions
• Leveraging AI-powered analytics and cloud-based data management systems

Access the detailed Autism Spectrum Disorder Diagnostics Market report here:
https://www.thebusinessresearchcompany.com/report/autism-spectrum-disorder-diagnostics-global-market-report

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. We have published over 17,500 reports across 27 industries and 60+ geographies. Our research is powered by 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

We provide continuous and custom research services, offering a range of specialized packages tailored to your needs, including Market Entry Research Package, Competitor Tracking Package, Supplier & Distributor Package and much more.

Disclaimer: Please note that the findings, conclusions and recommendations that TBRC Business Research Pvt Ltd delivers are based on information gathered in good faith from both primary and secondary sources, whose accuracy we are not always in a position to guarantee. As such TBRC Business Research Pvt Ltd can accept no liability whatever for actions taken based on any information that may subsequently prove to be incorrect. Analysis and findings included in TBRC reports and presentations are our estimates, opinions and are not intended as statements of fact or investment guidance.

Contact Us:
The Business Research Company
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email: info@tbrc.info

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.